Table 1. Criteria for Oral Anticoagulation Initiation and Interruption in the IMPACT Study.
Initiation Criteria | Interruption Criteria | |
---|---|---|
AHRE Duration (over 48 consecutive hours) | Consecutive days free from AHRE | |
CHADS2 Score | ||
1 and 2 | 48 hours | 30 days |
3 and 4 | 24 hours | 90 days |
5 and 6 or any prior stroke/TIA | ≤12 hours | Do not discontinue |